Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLD.

Yun Kyu Lee,Bo Kyung Koo,Sae Kyung Joo,Dong Hyeon Lee,Heejoon Jang,Jee Won Chai,Myoung Seok Lee,Si Won Jang,Young Ho So,Jeong Hwan Park,Mee Soo Chang,Won Kim

Alimentary pharmacology & therapeutics（2023）

引用 3|浏览8

暂无评分

摘要

Increased low-quality muscle mass, but not decreased normal-quality muscle mass, as assessed by a muscle quality map in CT, predicts fibrosis progression in patients with NAFLD.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要